Split History
ETFs Holding TROV »    TROV Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
TrovaGene is a clinical-stage medicine oncology therapeutics company. Co.'s main focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by using its Precision Cancer Monitoring® (PCM) technology in tumor genomics. Co.'s main drug candidate, PCM-075, is a Polo-like Kinase 1 selective adenosine triphosphate inhibitor. PCM-075 shown preclinical antitumor activity as a single agent and synergy in combination with more than 10 different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor. According to our TROV split history records, TrovaGene has had 4 splits.
TROV split history picture
TrovaGene (TROV) has 4 splits in our TROV split history database. The first split for TROV took place on May 30, 2012. This was a 1 for 6 reverse split, meaning for each 6 shares of TROV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split. TROV's second split took place on July 27, 2004. This was a 111 for 1 split, meaning for each share of TROV owned pre-split, the shareholder now owned 111 shares. For example, a 166.666666666667 share position pre-split, became a 18500 share position following the split. TROV's third split took place on June 04, 2018. This was a 1 for 12 reverse split, meaning for each 12 shares of TROV owned pre-split, the shareholder now owned 1 share. For example, a 18500 share position pre-split, became a 1541.66666666667 share position following the split. TROV's 4th split took place on February 20, 2019. This was a 1 for 6 reverse split, meaning for each 6 shares of TROV owned pre-split, the shareholder now owned 1 share. For example, a 1541.66666666667 share position pre-split, became a 256.944444444444 share position following the split.

When a company such as TrovaGene splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as TrovaGene conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the TROV split history from start to finish, an original position size of 1000 shares would have turned into 256.944444444444 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TrovaGene shares, starting with a $10,000 purchase of TROV, presented on a split-history-adjusted basis factoring in the complete TROV split history. TROV split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/20/2009
End date: 07/19/2019
Start price/share: $164.16
End price/share: $2.11
Dividends collected/share: $0.00
Total return: -98.71%
Average Annual Total Return: -35.29%
Starting investment: $10,000.00
Ending investment: $128.59
Years: 10.00
Date Ratio
05/30/20121 for 6
07/27/2004111 for 1
06/04/20181 for 12
02/20/20191 for 6
TROV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TTNP Split History
UHS Split History
UNIS Split History
USPH Split History
UTHR Split History
VAR Split History
VBIV Split History
VICL Split History
VIV Split History
VIVO Split History

Also explore: TROV shares outstanding history

Neuralstem, Inc. (CUR)
Francesca's Holdings Corporation (FRAN)
China Green Agriculture, Inc. (CGA)
Xenetic Biosciences, Inc. (XBIO)
Yuma Energy, Inc. (YUMA)
Avinger, Inc. (AVGR)
Sonoma Pharmaceuticals, Inc. (SOMA)
Hudson Global, Inc. (HSON)
Jaguar Health, Inc. (JAGX)
Cesca Therapeutics Inc. (KOOL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TROV Insider Buying

TROV Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.